PT - JOURNAL ARTICLE AU - Rao, Nandana D. AU - Kaganovsky, Jailanie AU - Malouf, Emily AU - Coe, Sandy AU - Huey, Jenna AU - Tsinajinne, Darwin AU - Hassan, Sajida AU - King, Kristine AU - Fullerton, Stephanie M. AU - Chen, Annie T. AU - Shirts, Brian H. TI - Diagnostic yield of genetic screening in a diverse, community-ascertained cohort AID - 10.1101/2022.12.20.22283637 DP - 2022 Jan 01 TA - medRxiv PG - 2022.12.20.22283637 4099 - http://medrxiv.org/content/early/2022/12/21/2022.12.20.22283637.short 4100 - http://medrxiv.org/content/early/2022/12/21/2022.12.20.22283637.full AB - Background Population screening for genetic risk of adult-onset preventable conditions has been proposed as an attractive public health intervention. Screening unselected individuals can identify many individuals who will not be identified through current genetic testing guidelines.Methods We sought to evaluate enrollment in and diagnostic yield of population genetic screening in a resource-limited setting among a diverse population. We developed a low-cost, short-read next-generation sequencing panel of 25 genes that had 98.4% sensitivity and 99.98% specificity compared to diagnostic panels. We used email invitations to recruit a diverse cohort of patients in the University of Washington Medical Center system unselected for personal or family history of hereditary disease. Participants were sent a saliva collection kit in the mail with instructions on kit use and return. Results were returned using a secure online portal. Enrollment and diagnostic yield were assessed overall, and across race and ethnicity groups.Results Overall, 40,857 people were invited and 2,899 (7.1%) enrolled. Enrollment varied across race and ethnicity groups, with the lowest enrollment among African American individuals (3.3%) and the highest among Multiracial or Other Race individuals (13.0%). Of 2,864 enrollees who received screening results, 106 actionable variants were identified in 103 individuals (3.6%). Of those who screened positive, 30.1% already knew about their results from prior genetic testing. The diagnostic yield was 74 new, actionable genetic findings (2.6%). The addition of more recently identified cancer risk genes increased the diagnostic yield of screening.Conclusions Population screening can identify additional individuals that could benefit from prevention, but challenges in recruitment and sample collection will reduce actual enrollment and yield. These should not be overlooked in intervention planning or in cost and benefit analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Brotman Baty Institute for Precision Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Washington IRB (00009032).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets generated and/or analyzed during the current study are not publicly available as they include some data from the University of Washington electronic health record and consent forms did not include broad data sharing. Deidentified datasets are available from the corresponding author on reasonable request.